Reappraise the advanced technique for tumor localization and sentinel lymph node assessment in clinical early-stage non–small cell lung cancer Chengwu.

Slides:

Advertisements

Similar presentations

Size matters: A comparison of T1 and T2 peripheral non–small-cell lung cancers treated with stereotactic body radiation therapy (SBRT) Neal E. Dunlap,

Advertisements

Lost in translation The Journal of Thoracic and Cardiovascular Surgery

Manuel J. Antunes, MD, PhD, DSc

Stephen R. Broderick, MD, MPHS

The eighth edition TNM stage classification for lung cancer: What does it mean on main street? Frank C. Detterbeck, MD The Journal of Thoracic and Cardiovascular.

One in every 14 patients with early-stage lung cancer is not being treated! Benny Weksler, MD, MBA The Journal of Thoracic and Cardiovascular Surgery

It is not just about surgery versus stereotactic ablative radiotherapy, it is about curing as many patients with lung cancer as possible Alessandro Brunelli,

Lung cancer screening: No more excuses

Yesterday's heroic measure is now standard procedure: Extracorporeal membrane oxygenation as a bridge to lung transplant Victor van Berkel, MD, PhD

Pulmonary vein stenosis: Challenges ahead

Outcomes of unexpected pathologic N1 and N2 disease after video-assisted thoracic surgery lobectomy for clinical stage I non–small cell lung cancer Hong.

Ground glass opacity of the lung: The veil that needs lifting

Victor van Berkel, MD, PhD

Thymoma with idiopathic thrombocytopenic purpura: Report of a case

The lord of the rings Antonio Miceli, MD, PhD

Is tissue the issue? Brian E. Louie, MD, MHA, MPH, FRCSC, FACS

The variability of the mitral valve anatomy and terminology

Yang Zhang, MD, Haiquan Chen, MD, PhD

Aditya K. Kaza, MD The Journal of Thoracic and Cardiovascular Surgery

Impact of positive pleural lavage cytology on survival in patients having lung resection for non–small-cell lung cancer: An international individual patient.

Innovation and science: The future of valve design

The assessment of cost effectiveness and the effectiveness of cost assessment in cardiothoracic surgery Vinay Badhwar, MD The Journal of Thoracic and.

It's not “just a shunt” but sometimes it should be…

Fixing the supply problem

Bartley P. Griffith, MD, FACS, FRCS

Management of stage IIIA (N2) non–small cell lung cancer: A transatlantic perspective Gaetano Rocco, MD, Katie Nason, MD, MPH, Alex Brunelli, MD, Gonzalo.

Military surgeons just want to have fun

Also Sprach Zarathustra

A first start for lung transplantation?

Required area of lymph node sampling during segmentectomy for clinical stage IA non– small cell lung cancer Hiroaki Nomori, MD, PhD, Yasuomi Ohba, MD,

Commentary: Tag, you're it

Stephen R. Broderick, MD, MPHS

The Journal of Thoracic and Cardiovascular Surgery

Joseph A. Dearani, MD, Michael J. Ackerman, MD, PhD

Michael Lanuti, MD The Journal of Thoracic and Cardiovascular Surgery

Yusuke Takahashi, MD, PhD, Prasad S. Adusumilli, MD

Resection of primary lung cancer with incidental pleural seeding: Seeds of change or reap what you sow? Jules Lin, MD The Journal of Thoracic and Cardiovascular.

Jeevanantham Rajeswaran, PhD, Eugene H. Blackstone, MD

Is parameter T staging influenced by tumor behavior?

Frozen elephant trunk technique: Ready to get back to the future?

Attachment disorder in thoracoabdominal surgery

Uma M. Sachdeva, MD, PhD, Daniela Molena, MD

Video-assisted resection for lung cancer results in fewer complications Lunxu Liu, PhD, MD, FRCS The Journal of Thoracic and Cardiovascular Surgery

We are the company we keep: The importance of the tumor microenvironment Sai Yendamuri, MD, FACS The Journal of Thoracic and Cardiovascular Surgery

Passing the torch The Journal of Thoracic and Cardiovascular Surgery

Sutureless valve implantation: Every detail counts

Prognosis and “granularity”: Building on staging foundations?

Functional tricuspid pathology: To treat or not to treat

Bryan M. Burt, MD The Journal of Thoracic and Cardiovascular Surgery

The Journal of Thoracic and Cardiovascular Surgery

Discussion The Journal of Thoracic and Cardiovascular Surgery

Keep it short and sweet Ian A. Makey, MD, Scott B. Johnson, MD

The future of cardiac surgery training: A survival guide

Linda W. Martin, MD, MPH, FCCP, FACS, Gail E

Robert J. Cerfolio, MD, FACS, FCCP, Ayesha S. Bryant, MSPH, MD

The continuing challenge of congenital heart disease in China

Between a rock and a hard place

Size matters: A comparison of T1 and T2 peripheral non–small-cell lung cancers treated with stereotactic body radiation therapy (SBRT) Neal E. Dunlap,

The Journal of Thoracic and Cardiovascular Surgery

“The more things change…”: The challenges ahead

Aritoshi Hattori, MD, Kenji Suzuki, MD

The Journal of Thoracic and Cardiovascular Surgery

Lung cancer randomized controlled trials should compare stereotactic body radiation therapy with observation, NOT surgery Raja M. Flores, MD The Journal.

Who should decide margin length in pulmonary excision of lung cancer?

Is there a benefit to continuing with resection of all sites of disease when clinically occult pleural metastases from non–small cell carcinoma are found?

Did you like Terminator 3 better than Terminator 2

Samuel Kim, MD The Journal of Thoracic and Cardiovascular Surgery

A good chimney requires a good sweep

Journal changes and initiatives

Deciding how much to pay for effective care

Presentation transcript:

Reappraise the advanced technique for tumor localization and sentinel lymph node assessment in clinical early-stage non–small cell lung cancer Chengwu Liu, MD, PhD, Lunxu Liu, MD, PhD, FRCS The Journal of Thoracic and Cardiovascular Surgery Volume 154, Issue 3, (September 2017) DOI: 10.1016/j.jtcvs.2017.05.080 Copyright © 2017 The American Association for Thoracic Surgery Terms and Conditions

The Journal of Thoracic and Cardiovascular Surgery 2017 154, DOI: (10 The Journal of Thoracic and Cardiovascular Surgery 2017 154, DOI: (10.1016/j.jtcvs.2017.05.080) Copyright © 2017 The American Association for Thoracic Surgery Terms and Conditions